https://www.selleckchem.com/pr....oducts/Pyroxamide(NS
Background Data about the impact of left atrial appendage thrombosis (LAAT) on early safety and mortality in patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI) are scarce. We aimed to investigate the incidence and predictors of LAAT and the outcome associated with this condition in patients treated by TF-TAVI. Methods Retrospective data analysis derived from a prospective single-center registry comparing patients with and without LAAT regarding early safety at 30-days according to Valve Aca
Like
Comment
Share
